Drug intelligence / Profile preview

(2S)-3-(1-{[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1H-indol-5-yl)-2-ethoxypropanoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C24H23ClN2O4 and a molecular weight of approximately 438.9 g/mol. It contains an indole core substituted with an oxazole ring and a chlorophenyl group. The drug is classified as experimental and has not been approved for any indication in the US or elsewhere. There are no known clinical trials or patents associated with this molecule, and its mechanism of action as well as therapeutic targets have not been established in public databases. No information on its pharmacological activity or intended use is available from current sources.[1][7][9]

Other names
(2S)-3-(1-{[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1H-indol-5-yl)-2-ethoxypropanoic acid1H-Indole-5-propanoic acid, 1-[[2-(2-chlorophenyl)-5-methyl–4–oxazolyl]methyl]-alpha–ethoxy-, (alphaS)Acide (2S)–3–(1–{[2–(2–chlorophényl)–5–méthyl–1,3–oxazol–4— yl]}méthyl}— 1H-indol—5— yl)—  éthoxypropanoïque
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on (2S)-3-(1-{[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1H-indol-5-yl)-2-ethoxypropanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2S)-3-(1-{[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1H-indol-5-yl)-2-ethoxypropanoic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call